Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers

Eli Lilly’s shares rose 4% in early morning trading after reporting revenue of $24.4 billion, well past consensus estimates.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top